Sanofi-Aventis sees product setbacks, drops merger plans with BMS
French drugmaker Sanofi-Aventis suffered a series of setbacks over the past week involving two of its key products, and a ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
The e-mail address(es) that you supply to use this service will only be used to send the requested article.